Contingent Value Rights in M&A Deals: Bridging Valuation Gaps, Structuring Deals to Protect Buyers and Sellers

Mr. Bab has worked extensively on public and private acquisitions, divestitures and joint ventures, including cross-border transactions for both private equity and corporate clients, as well as licensing arrangements and other corporate transactions. He has experience across many industries but is particularly active in the healthcare and life sciences sectors. In addition, he frequently advises Deutsche Bank, Guggenheim Securities, J.P. Morgan Securities, Morgan Stanley and other investment banks on major M&A transactions. Mr. Bab is also a frequent speaker on legal developments affecting mergers and acquisitions and on healthcare-related issues.

Mr. Goldfeld's practice is focused on domestic and cross-border mergers and acquisitions, divestitures, spin-offs, joint ventures, private equity transactions and other complex corporate and securities law matters. He has represented a broad range of clients in a variety of industries. Mr. Goldfeld is Co-Chair of the International Private Equity & Venture Capital Committee of the American Bar Association’s International Law Section and is a Fellow of the American Bar Foundation.

Ms. Hochenberg focuses her practice on mergers and acquisitions, corporate governance and shareholder activism defense. She is a thought leader and frequent speaker on emerging trends in M&A and corporate governance law and is currently Vice Chair of the ABA's Acquisition of Public Companies Subcommittee. Ms. Hochenberg has worked on some of the biggest and most transformative M&A transactions of our time, both purely US as well as cross-border. Her clients have included Afterpay, Atlas Air Worldwide, bp, Cable One, Canadian National Railway, Cincinnati Bell, City Brewing, CommScope, Crown Castle, Exyte, GW Pharmaceuticals, Johnson & Johnson, Light & Wonder, Moda Operandi, NCR, Novartis, Pitney Bowes, Scientific Games, Time Warner, US Foods, Viatris and Yahoo.